Article Information
History
- September 24, 2021.
Article Versions
- You are currently viewing Version 1 of this article (September 24, 2021 - 12:38).
- Version 2 (February 28, 2022 - 08:37).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- 1Universidad Cardenal Herrera CEU, Elche
- 2Instituto de Neurociencias UMH-CSIC. Alicante
- 3Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel
- ↵*Corresponding author Jorge R Brotons-Mas, e-mail: Jorge.brotonsmas{at}chceu.es, Address: Universidad CEU Cardenal Herrera; Plaza Reyes Católicos, 19. 03204 Elche – Alicante, Spain, Instituto de Neurocienicas UMH-CSIC; Avd Ramón y Cajal SN, Edificio Ramón y Cajal, 03550,San Juan de Alicante, Alicante, Spain. Tel. +34965426486